SCHEMBL23797003

SCHEMBL23797003

CCOC(=O)/N=C(/N)NCCCCCC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.39
▸ EPHX2 P34913 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ NAMPT P43490 1/20 0.36
▸ EPHX1 P07099 3/20 0.35
▸ CASP2 P42575 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ ALOX15 P16050 1/20 0.34
▸ FAAH O00519 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SOAT1 P35610 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ EGLN1 Q9GZT9 1/20 0.34
▸ GRIN2D O15399 1/20 0.34
▸ GRIN3B O60391 1/20 0.34
▸ GRIN1 Q05586 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23797004 1.00 GAA (0.39) GAAEPHX2ALDH1A1NAMPTEPHX1
SCHEMBL24178194 0.86 ACHE (0.43) EPHX1KMT2A
SCHEMBL24177671 0.86 KDM4E (0.47) ALDH1A1ADRA1AALOX15FAAHMEN1
SCHEMBL24177707 0.86 PAOX (0.44) ALOX15CYP1A2EGLN1GRIN2DGRIN3B
SCHEMBL24178196 0.86 KDM4E (0.47) ALDH1A1ADRA1AALOX15FAAHMEN1
SCHEMBL23796909 0.86 ACHE (0.43) EPHX1KMT2A
SCHEMBL23797006 0.84 GAA (0.36) GAAEPHX2ALDH1A1NAMPTEPHX1
SCHEMBL23797008 0.84 GAA (0.36) GAAEPHX2ALDH1A1NAMPTEPHX1
SCHEMBL17234488 0.81 EGLN1 (0.40) GAAALDH1A1ALOX15FAAHCYP1A2
SCHEMBL18528394 0.81 EGLN1 (0.40) GAAALDH1A1ALOX15FAAHCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3877439-B1 ANALGESIC AND ANTI-ADDICTIVE COMPOSITIONS FOR TREATMENT OF CHRONIC PAIN AND OPIOID ADDICTION UNIV MINNESOTA (US) 2026-03-11 — — EP claimed
US-12098118-B2 Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-09-24 — — US claimed
US-20220002238-A1 ANALGESIC AND ANTI-ADDICTIVE COMPOSITIONS FOR TREATMENT OF CHRONIC PAIN AND OPIOID ADDICTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2022-01-06 — — US claimed
EP-3877439-A2 ANALGESIC AND ANTI-ADDICTIVE COMPOSITIONS FOR TREATMENT OF CHRONIC PAIN AND OPIOID ADDICTION Regents of the University of Minnesota (US) 2021-09-15 — — EP claimed
EP-3877439-B1 ANALGESIC AND ANTI-ADDICTIVE COMPOSITIONS FOR TREATMENT OF CHRONIC PAIN AND OPIOID ADDICTION UNIV MINNESOTA (US) 2026-03-11 — — EP disclosed
US-12098118-B2 Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002238-A1 ANALGESIC AND ANTI-ADDICTIVE COMPOSITIONS FOR TREATMENT OF CHRONIC PAIN AND OPIOID ADDICTION OPRK1, OPRM1, OPRD1 GAA 1332/4885EPHX2 2127/4885ALDH1A1 341/4885
US-12098118-B2 Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction OPRK1, OPRM1, OPRD1 GAA 1332/4885EPHX2 2127/4885ALDH1A1 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback